Navigation Links
MedCath Corporation Reports Fourth Quarter Earnings and Outlook for Fiscal 2008
Date:11/13/2007

ignificant economic, regulatory and competitive uncertainties and contingencies that are difficult or impossible to predict accurately and are beyond our control including, but not limited to, enactment of changes in federal law that would limit physician hospital ownership. Actual results could differ materially from those projected in these forward- looking statements. We do not assume any obligation to update these statements in a news release or otherwise should material facts or circumstances change in ways that would affect their accuracy.

These various risks and uncertainties are described in detail in "Risk Factors" in MedCath's Registration Statement on Form S-3/A filed with the Securities and Exchange Commission on March 29, 2007 and its Quarterly Report on Form 10-Q for the quarter ended June 30, 2007. Copies of this registration statement and Form 10-Q, including exhibits, are available on the internet site of the Securities and Exchange Commission at http://www.sec.gov.

MEDCATH CORPORATION

CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share data)

(Unaudited)

Three Months Ended Twelve Months Ended

September 30, September 30,

2007 2006 2007 2006

Net revenue $158,641 $177,444 $718,959 $706,374

Operating expenses:

Personnel expense 51,976 55,472 229,844 228,350

Medical supplies expense 42,907 47,684 192,036 196,046

Bad debt expense 10,005 14,395 55,162 56,845

Other operating expenses 31,145 35,008 142,584 141,498

Pre-opening expenses 555
'/>"/>

SOURCE MedCath Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
2. Brooke Franchise Corporation Announces Selected July Results
3. MedThink Communications Retained by NanoBio Corporation
4. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
5. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
6. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
7. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
8. LifeQuest World Corporation Proud Contributor to Dietary Supplement Education Alliance (DSEA)
9. DTI Medical Corporation Announces Reverse Split and Other Corporate Developments
10. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer
11. AGA Medical Corporation Receives Approval for the AMPLATZER Muscular Ventricular Septal Defect Occluder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... ... September 02, 2015 , ... Ovarian cancer continues to be the deadliest ... getting ovarian cancer in her lifetime is approximately 1 in 75. This year it ... and 14,000 will die. , There is no test to detect ovarian cancer. ...
(Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... ... PHYTOMER, the pioneer in marine cosmetics introduces PIONNIÈRE XMF Perfection Youth Rich ... new cream combines breakthrough biotechnological anti-aging power with a lipid-replenishing marine oil for ...
(Date:9/2/2015)... , ... September 02, 2015 , ... ... business services, has been named to the Inc. 5000 List, an independent ... publishing this list for 34 years, and this achievement puts Canopy in rarefied ...
(Date:9/2/2015)... ... September 02, 2015 , ... Traveling to the Caribbean can be an amazing ... and fauna. , Lifestyle Holidays Vacation Club knows that Puerto Plata ... experience that much better, Lifestyle Holidays Vacation Club has put together its list of ...
(Date:9/1/2015)... FL (PRWEB) , ... September 01, 2015 , ... September ... about this disease that affects more than 233,000 men each year in the United ... is the most common non-skin cancer in America, affecting 1 in 7 men. One ...
Breaking Medicine News(10 mins):Health News:National Ovarian Cancer Coalition's DFW Chapter Features First Annual Teal Lights Display This Friday, September 4th, "National Wear Teal Day" 2Health News:National Ovarian Cancer Coalition's DFW Chapter Features First Annual Teal Lights Display This Friday, September 4th, "National Wear Teal Day" 3Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 2Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 3Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 4Health News:Canopy Partners Named to 2015 Inc. 5000 Fastest Growing Companies List 2Health News:Lifestyle Holidays Vacation Club Lists 3 Things to Consider When On a Puerto Plata Vacation 2Health News:Lifestyle Holidays Vacation Club Lists 3 Things to Consider When On a Puerto Plata Vacation 3Health News:September is Prostate Cancer Awareness Month 2Health News:September is Prostate Cancer Awareness Month 3
... in BJOG: An International Journal of Obstetrics and Gynaecology ... and placental abruption during the subsequent pregnancies of ... ,Placental praevia is defined as the implantation of ... the cervix. Placenta abruption is the premature separation of ...
... a campaign to encourage Hispanics to eat healthier food, ... U.S. Hispanics increased from 11.6% in 1991 to 23.7% ... obese and two times more likely to have diabetes ... ,LNC's campaign features a "Latin American ...
... their lives to work- related cancers and heart attacks can ... laws state that they no longer need to prove ... due the dead workers family. , The ... will be presumed to have been work-related when contracted by ...
... the US. A Defence Department panel has warned that ... serious challenge on two fronts. ,One, soldiers are ... at the current level of staffing and funds, the military ... necessary statement. ,In a damning revelation, the ...
... is no dearth of "anti-aging" products and surgeries in ... women go for them not just to enhance their looks, ... competitive enough in the market place, many observers point out. ... toxin. The toxin blocks the transmission of acetylcholine from the ...
... in 70 schoolchildren, available data says. The question is whether ... joint team of scientists from the King's College London ... up a seven-year study and hope to rope in 480 ... studied are between four and 11 months and already have ...
Cached Medicine News:Health News:Placental Problems in Women Linked With Caesarean Section 2Health News:Ontario Grants Fast-Track Compensation Rights for Work-Related Illnesses 2Health News:Ontario Grants Fast-Track Compensation Rights for Work-Related Illnesses 3Health News:One Third of US Troops Suffer from Mental Health Problems 2Health News:One Third of US Troops Suffer from Mental Health Problems 3Health News:More and More American Women Go for Facelifts to Get Jobs 2Health News:UK Scientists to Undertake Seven Year Study of Peanut Allergy 2
(Date:9/2/2015)... Md. , Sept. 2, 2015  RegeneRx ... a clinical-stage drug development company focused on tissue ... J.J. Finkelstein , President and Chief Executive Officer, ... & Renshaw Global Investment Conference, sponsored by ... be held September 8-10, 2015 at the St. ...
(Date:9/2/2015)... PAUL, Minn. , Sept. 2, 2015  MGC ... today scheduled a conference call to discuss its financial ... July 31, 2015. The call will be at 4:30 ... will report financial results for the third quarter of ... 10, 2015. Participants can dial (877) ...
(Date:9/2/2015)... YORK , Sept. 2, 2015 Relmada ... novel therapies for the treatment of chronic pain, announced ... meetings at both the FBR Second Annual Healthcare Conference ... as follows: FBR Second Annual Healthcare Conference ... Boston No presentation, investor ...
Breaking Medicine Technology:RegeneRx to Present at Rodman & Renshaw Global Investment Conference 2RegeneRx to Present at Rodman & Renshaw Global Investment Conference 3MGC Diagnostics Corporation to Report Third Quarter Fiscal 2015 Financial Results on Thursday, September 10, 2015 2Relmada Therapeutics to Participate in Two Upcoming Investor Conferences 2
... 2007 - Inotek,Pharmaceuticals Corporation announced today the ... the safety of INO-1001,as well as the ... for,cardiac reperfusion injury. The study was conducted ... undergoing,primary percutaneous coronary intervention. The presentation was,made ...
... 2007--A new study shows that as rates,of diabetes ... disease (CVD) linked to diabetes has also,increased. , ... to,prevent diabetes and to aggressively treat and control ... the investigators,from the long-standing Framingham Heart Study, a ...
Cached Medicine Technology:Inotek Pharmaceuticals Announces Presentation of Phase 2 Clinical,Data for INO-1001 at ACC Demonstrating PARP Inhibition and,Anti-inflammatory Activity in Plasma of Patients Undergoing Primary,Percutaneous Coronary Intervention 2Inotek Pharmaceuticals Announces Presentation of Phase 2 Clinical,Data for INO-1001 at ACC Demonstrating PARP Inhibition and,Anti-inflammatory Activity in Plasma of Patients Undergoing Primary,Percutaneous Coronary Intervention 3Inotek Pharmaceuticals Announces Presentation of Phase 2 Clinical,Data for INO-1001 at ACC Demonstrating PARP Inhibition and,Anti-inflammatory Activity in Plasma of Patients Undergoing Primary,Percutaneous Coronary Intervention 4Increasing Proportion of Cardiovascular Disease Due to Diabetes,Over the Last 50 Years 2Increasing Proportion of Cardiovascular Disease Due to Diabetes,Over the Last 50 Years 3
Thesystem combines an exclusive dual light-source design and a versatile sample compartment to provide solid, reliable performance....
Inquire...
The Spex SkinSkan is the only in-vivo, fibre-optic spectrofluorometer designed specifically for skin-fluorescence measurements. It is also ideal for many remote sensing steady-state fluorescence appl...
The unique RF-1501 optical design provides exceptional sensitivity in an incredibly compact instrument....
Medicine Products: